A correlation between MYCN amplification and a cold tumor phenotype has been reported in NB, but MYCN amplification also correlates with 1p36 deletion, which we confirmed using the UCSC Xena Database to investigate patient TARGET data from >700 patient samples (Fig. 1A) 27. Here, MYCN is linked to neoplasm.